trending Market Intelligence /marketintelligence/en/news-insights/trending/upV3Nx4TFSbzGhbA4OycKw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

1315 Capital acquires medical device coating manufacturer Biocoat

Banking Essentials Newsletter - November Edition

University Essentials | COVID-19 Economic Outlook in Banking: Rates and Long-Term Expectations: Q&A with the Experts

Estimating Credit Losses Under COVID-19 and the Post-Crisis Recovery

StreetTalk – Episode 70: Banks' Liquidity Conundrum Could Fuel M&A Activity

1315 Capital acquires medical device coating manufacturer Biocoat

Healthcare investment firm 1315 Capital LLC purchased Biocoat Inc. for an undisclosed amount.

The acquired company provides contract and original equipment manufacturers with hydrophilic biomaterial coatings for medical devices used in the neurovascular, cardiovascular, peripheral and ophthalmic markets. The acquisition is expected to help Biocoat further expand its research and development efforts and reach more customers.

Philadelphia-based 1315 Capital invests in commercial-stage healthcare services, medical technology and specialty pharmaceutical companies.